An international news service reports that a CEO speaking at an investment conference criticized two companies for partnering to distribute a drug. The CEO contends the two companies are cooperating only in order to make drug prices higher. One of the companies recently paid $100 million to settle a lawsuit which contends that after buying another firm, this company raised the price of a vial of medication from $40 to $34,000. The company spokesman criticized the CEO’s speech as not correct.
Read more: Jim Chanos slams Express Scripts and Mallinckrodt over high drug prices
